LOGIN
Combined IV & topical TXA reduces blood loss and transfusion rate in THA
August 2016
Combined IV & topical TXA reduces blood loss and transfusion rate in THA
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:1
Tranexamic Acid Administration in Primary Total Hip Arthroplasty: A Randomized Controlled Trial of Intravenous Combined with Topical Versus Single-Dose Intravenous Administration
J Bone Joint Surg Am. 2016 Jun 15;98(12):983-91Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
150 patients scheduled for primary unilateral total hip arthroplasty were randomized to one of three groups: a combined intravenous (IV) and topical tranexamic acid (TXA) protocol, IV TXA alone with topical placebo administration, or intravenous and topical placebo administration. The purpose of this study was to determine if the combined administration protocol demonstrated significantly greater ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.